The splicing factor RBM4 controls apoptosis, proliferation, and migration to suppress tumor progression. - Wikidata - awgldk - TriplyDB

The splicing factor RBM4 controls apoptosis, proliferation, and migration to suppress tumor progression.

The splicing factor RBM4 controls apoptosis, proliferation, and migration to suppress tumor progression.

http://www.wikidata.org/entity/Q34157516

about

Engineering RNA-binding proteins with diverse activities Aberrant splicing and drug resistance in AML Differential Impacts of Alternative Splicing Networks on Apoptosis Large-scale analysis of genome and transcriptome alterations in multiple tumors unveils novel cancer-relevant splicing networks Misregulation of Alternative Splicing in a Mouse Model of Rett Syndrome The ovarian cancer oncobiome.Efficient backsplicing produces translatable circular mRNAs.Transcriptome-wide identification and study of cancer-specific splicing events across multiple tumors.Global Profiling of the Cellular Alternative RNA Splicing Landscape during Virus-Host Interactions A forward genetic screen reveals novel independent regulators of ULBP1, an activating ligand for natural killer cells.Transcriptome-wide analysis of alternative RNA splicing events in Epstein-Barr virus-associated gastric carcinomas The impact of RNA binding motif protein 4-regulated splicing cascade on the progression and metabolism of colorectal cancer cells.RBM4a-regulated splicing cascade modulates the differentiation and metabolic activities of brown adipocytes.Quantitative proteomic analyses of mammary organoids reveals distinct signatures after exposure to environmental chemicals.Trop2 is overexpressed in gastric cancer and predicts poor prognosis.A splicing isoform of TEAD4 attenuates the Hippo-YAP signalling to inhibit tumour proliferation Prognostic value of decreased expression of RBM4 in human gastric cancer RNA splicing factors as oncoproteins and tumour suppressors.RBM4 Regulates Neuronal Differentiation of Mesenchymal Stem Cells by Modulating Alternative Splicing of Pyruvate Kinase M The impact of the RBM4-initiated splicing cascade on modulating the carcinogenic signature of colorectal cancer cells.Pre-mRNA splicing in cancer: the relevance in oncogenesis, treatment and drug resistance.SF3B4 is decreased in pancreatic cancer and inhibits the growth and migration of cancer cells.Alternative splicing: the pledge, the turn, and the prestige : The key role of alternative splicing in human biological systems.The MBNL3 splicing factor promotes hepatocellular carcinoma by increasing PXN expression through the alternative splicing of lncRNA-PXN-AS1.Pharmacology of Modulators of Alternative Splicing.Global analysis of physical and functional RNA targets of hnRNP L reveals distinct sequence and epigenetic features of repressed and enhanced exons.Alternative splicing and cell survival: from tissue homeostasis to disease.Decrease of RBM4 indicates poor prognosis in patients with hepatocellular carcinoma after hepatectomy EMT and stemness: flexible processes tuned by alternative splicing in development and cancer progression.HnRNP-L promotes prostate cancer progression by enhancing cell cycling and inhibiting apoptosis.A large-scale analysis of alternative splicing reveals a key role of QKI in lung cancer.An extensive program of periodic alternative splicing linked to cell cycle progression.Dysregulated cellular functions and cell stress pathways provide critical cues for activating and targeting natural killer cells to transformed and infected cells.A transcriptomic insight into the impacts of mast cells in lung, breast, and colon cancers.Post-Transcriptional Regulation of Anti-Apoptotic BCL2 Family Members.hnRNP A1/A2 and Sam68 collaborate with SRSF10 to control the alternative splicing response to oxaliplatin-mediated DNA damage.Loss of TDP43 inhibits progression of triple-negative breast cancer in coordination with SRSF3.Alternative-splicing defects in cancer: Splicing regulators and their downstream targets, guiding the way to novel cancer therapeutics.Expanding RNA binding specificity and affinity of engineered PUF domains.Apoptotic Cell-Derived Extracellular Vesicles Promote Malignancy of Glioblastoma Via Intercellular Transfer of Splicing Factors.

P2860

Q26795472-9B29CD1E-0BC5-4D08-9A14-31F967F02692 Q28076011-186A4F35-909A-4A51-A87D-923D211D7BF9 Q28078238-F5E637F5-80C0-4753-9A8D-CDBD90FCFFAF Q28275692-AF99060A-4782-48BC-8E1C-A0B5885CFB01 Q28552209-10C784C8-7694-49C6-BF2C-E5012E12B4AD Q33829460-065653B2-51BC-4636-8AC0-7AD5C82F0D8D Q35113609-7F287819-FC62-4227-9956-8DE0765C4DD2 Q35740083-02F042E3-0EBA-43C6-9A53-90B010BDBA7D Q36124078-FA4050D0-CEA1-4378-83BD-AB2ABAF0C39A Q36238117-92FB7372-57C2-4931-8B1E-A9BA76B944A1 Q36368952-EFACEA8F-02F8-4827-9DE1-DB498EB71285 Q36545961-406B461E-9F42-45E7-9685-A895C4F6FC1B Q36560029-8200CD4C-03DB-4943-964D-2385264CC171 Q36684669-395A318A-570F-4E55-91BA-F18900B50627 Q36905863-F1BAF6E6-8A3E-429E-AE46-EB96AB8F82ED Q37010219-43666742-5EB0-49D5-9BB6-FE5832324AD8 Q37024168-7869517E-5A99-4DB7-BD19-7719BE8847F1 Q37391660-1A747259-81EB-4319-A921-ECFED257A0EA Q37595173-1032968F-CD1E-4F66-9814-902002EC6498 Q37690348-C005BE32-B45C-450B-AB4C-1447DB89D1A0 Q38286217-F4DB056F-1EBD-467F-B60F-0A30C7A185E9 Q38709877-1369C1AC-6FA0-4697-AE58-FB01778132CD Q38735423-F2182A0C-69C8-43B3-9124-5061AFB9F9F2 Q38758644-BF5B7DF9-9E7A-4ACA-A9DE-A30FCC10E12A Q38776406-DE62B191-D47E-4945-8612-61E5C8FA4DA4 Q38830228-88E38CAF-1316-49D0-B80F-64E9EDAB1DF7 Q38968877-295782FB-530E-4048-A8FF-F139990340D7 Q38990901-10E53E84-A9BA-4227-8B46-22A0F121A29D Q39109931-8BC9F9E3-E0A2-446B-9734-7177E41F32DD Q42054769-FC3B97DD-0BC0-42C0-BCC1-B6ACFAC9678C Q42176799-536C8155-5EB0-4755-9C32-A53A2C71366D Q42754639-0F01BE51-F481-40A2-A72B-D6174C6BB07B Q46091631-A9047BD9-E9D5-435E-8A41-0DA373E0F3C9 Q47306770-DA395C5B-6333-42F0-BDD9-89FBD45FAC6C Q47716556-0AE5689D-6BB4-46D8-862C-E27BE270B595 Q49168157-39DB841B-572C-4FB3-A617-2A037352047B Q52341074-EB9D16EC-DE69-42AE-89FF-6C4F5D8380BA Q52564290-EF328201-A777-49AE-954B-C1255E1B7AA9 Q52681299-64579DC3-20A6-43BE-8F1A-A5454E956DBE Q55456769-68783904-3A59-4BE0-AED3-6509407BC343

P2860

The splicing factor RBM4 controls apoptosis, proliferation, and migration to suppress tumor progression.

http://www.wikidata.org/entity/Q34157516

description

2014 nî lūn-bûn

@nan

2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

The splicing factor RBM4 contr ...... to suppress tumor progression.

@ast

The splicing factor RBM4 contr ...... to suppress tumor progression.

@en

The splicing factor RBM4 contr ...... to suppress tumor progression.

@nl

type

label

The splicing factor RBM4 contr ...... to suppress tumor progression.

@ast

The splicing factor RBM4 contr ...... to suppress tumor progression.

@en

The splicing factor RBM4 contr ...... to suppress tumor progression.

@nl

prefLabel

The splicing factor RBM4 contr ...... to suppress tumor progression.

@ast

The splicing factor RBM4 contr ...... to suppress tumor progression.

@en

The splicing factor RBM4 contr ...... to suppress tumor progression.

@nl

P1433

Q34157516-7F700C88-A709-45CF-AB6D-57777A73411B

P1476

Q34157516-906BD7FE-526F-49C9-BAD2-F23EB54BB662

P2093

Q34157516-4FCB9023-EC47-469F-A062-5012A337AFFC

Q34157516-5B26AFF8-F70E-428C-862C-1FD43892B8BC

Q34157516-60112610-504F-4505-8FB4-DC9C90ADA295

Q34157516-864558E1-8FC1-4B66-B684-3C5E5C54EF55

Q34157516-9B0DD4F4-D4A1-4F50-8BF0-7C613331DA62

Q34157516-9EAAB61C-E714-403E-B8AA-43DEBC10B8B5

Q34157516-E081340D-6E60-4E01-8F1E-0865F61B6310

Q34157516-F056F136-D9C4-42E2-8322-2DD35D3C0228

P2860

Q34157516-0DD0D677-0BBB-4449-8723-665F4801CB1E

Q34157516-11B17B28-51A4-471D-AA1C-D2F27690E6D6

Q34157516-16B6DE17-6EB0-4548-AC66-EBC421779D65

Q34157516-1D4D8063-4558-433A-8953-D7CF54CF3A8C

Q34157516-22D64AD6-A407-4065-AD59-81215B0B0E72

Q34157516-23A99BF9-F01B-48B2-AC98-EEE60BAD9A4B

Q34157516-28C95E5D-760F-402E-BE11-B26F5758E6E4

Q34157516-298BFAF8-7F97-443C-821E-CC09235D055F

Q34157516-34A52F4B-A245-4AB6-B0DB-8059D9223643

Q34157516-3C7B6E9B-FA5C-4B7B-B97E-BF09D7600DC1

P304

Q34157516-B22CA7D6-8160-42E4-A69E-4C1F9FBDF651

P31

Q34157516-6879CE8A-AD2D-40A1-AC31-D4A8ED7C7A3C

P356

Q34157516-257EAB99-7B26-4A23-868C-68979E69D3A0

P433

Q34157516-1489606F-873A-44C7-8F11-DD770C4423B8

P478

Q34157516-3A0BBF88-2354-4A0A-AB29-DDF605656DC7

P577

Q34157516-B60610F8-C1D7-4C22-83A5-359DFBD55B09

P698

Q34157516-CC545D5B-83A3-4E75-ADAB-0CE40FA7326E

P932

Q34157516-021E1875-6535-4523-A867-5E116EC24210

P356

J.CCR.2014.07.010

P1433

P1476

The splicing factor RBM4 contr ...... to suppress tumor progression.

@en

P2093

Dan Chen

http://www.w3.org/2001/XMLSchema#string

Daniel Dominguez

http://www.w3.org/2001/XMLSchema#string

Haili Qian

http://www.w3.org/2001/XMLSchema#string

Quentin Liu

http://www.w3.org/2001/XMLSchema#string

Shujuan Shao

http://www.w3.org/2001/XMLSchema#string

Yang Wang

http://www.w3.org/2001/XMLSchema#string

Yihsuan S Tsai

http://www.w3.org/2001/XMLSchema#string

Zefeng Wang

http://www.w3.org/2001/XMLSchema#string

P2860

Exon selection in alpha-tropomyosin mRNA is regulated by the antagonistic action of RBM4 and PTB.

RBM4 interacts with an intronic element and stimulates tau exon 10 inclusion

Cell stress modulates the function of splicing regulatory protein RBM4 in translation control

A novel splicing regulator shares a nuclear import pathway with SR proteins

BIN1 is a novel MYC-interacting protein with features of a tumour suppressor

RNA-binding motif protein 4 translocates to cytoplasmic granules and suppresses translation via argonaute2 during muscle cell differentiation

The Bcl-2 apoptotic switch in cancer development and therapy

Splicing regulation: from a parts list of regulatory elements to an integrated splicing code

Structure-guided design of a selective BCL-X(L) inhibitor

Regulation of apoptosis by alternative pre-mRNA splicing

P304

374-389

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.CCR.2014.07.010

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

26

http://www.w3.org/2001/XMLSchema#string

P577

2014-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25203323

http://www.w3.org/2001/XMLSchema#string

P932

4159621

http://www.w3.org/2001/XMLSchema#string